XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.4
PARENT COMPANY ONLY FINANCIAL INFORMATION
12 Months Ended
Dec. 31, 2022
PARENT COMPANY ONLY FINANCIAL INFORMATION  
PARENT COMPANY ONLY FINANCIAL INFORMATION

NOTE 23 - PARENT COMPANY ONLY FINANCIAL INFORMATION

The Condensed Balance Sheets, Statements of Income, and Statements of Cash Flows for the Company (Parent Only) are presented below:

Condensed Balance Sheets

December 31, 

Assets

2022

2021

Cash and due from banks

$

7,195

$

19,883

Investment in subsidiary

 

274,092

 

277,390

Other assets

 

704

 

407

Total assets

$

281,991

$

297,680

Liabilities and Stockholders' Equity

 

 

Subordinated notes, net

 

49,461

 

49,394

Other liabilities

833

 

779

Total liabilities

 

50,294

 

50,173

Stockholders' equity

 

231,697

 

247,507

Total liabilities and stockholders' equity

$

281,991

$

297,680

Condensed Statements of Income

Year Ended December 31, 

    

2022

    

2021

    

2020

Interest expense on subordinated note

$

(1,942)

$

(1,722)

$

(776)

Dividends received from subsidiary

9,110

9,800

20,862

Other expenses

 

(274)

 

(272)

 

(195)

Income before income tax benefit and equity in undistributed net income of subsidiary

 

6,894

 

7,806

 

19,891

Income tax benefit

 

465

 

419

 

204

Equity in undistributed earnings of subsidiary

22,290

29,187

19,169

Net income

$

29,649

$

37,412

$

39,264

Condensed Statements of Cash Flows

     

Year Ended December 31, 

    

2022

    

2021

    

2020

Cash flows from operating activities:

Net income

$

29,649

$

37,412

$

39,264

Equity in undistributed net income of subsidiary

 

(22,290)

 

(29,187)

 

(19,169)

Amortization

 

67

 

61

 

115

ESOP compensation expense for allocated shares

 

 

1,482

 

1,025

Share-based compensation expense related to stock options and restricted stock

 

1,971

 

1,446

 

1,020

Changes in operating assets and liabilities

Other assets

 

(297)

 

(205)

 

(30)

Other liabilities

 

55

 

569

 

27

Net cash from operating activities

 

9,155

 

11,578

 

22,252

Cash flows (used by) from investing activities:

 

  

 

  

 

  

Net proceeds from ESOP

 

 

291

 

282

Investment in subsidiary

(25,000)

Net cash from (used by) investing activities

 

 

(24,709)

 

282

Cash flows (used by) from financing activities:

 

  

 

  

 

  

Net proceeds from issuance of subordinated notes

49,333

Repayment of subordinated notes

(10,000)

Proceeds (disbursements) from stock options exercised

 

568

 

(2,076)

 

(161)

Common stock repurchased for employee/director taxes paid on restricted stock awards

(190)

(211)

(34)

Issuance of common stock - employee stock purchase plan

503

Common stock repurchased

 

(15,628)

 

(13,961)

 

(9,802)

Dividends paid on common stock

(7,096)

(4,602)

(3,574)

Net cash (used by) from financing activities

 

(21,843)

 

18,483

 

(13,571)

Net (decrease) increase in cash and cash equivalents

 

(12,688)

 

5,352

 

8,963

Cash and cash equivalents, beginning of year

 

19,883

 

14,531

 

5,568

Cash and cash equivalents, end of year

$

7,195

$

19,883

$

14,531